• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于前列腺癌治疗的新型含氮甾体衍生物。

Novel Nitrogen Containing Steroid Derivatives for Prostate Cancer Treatment.

机构信息

V.N. Orekhovich Institute of Biomedical Chemistry, 10, Pogodinskaya Street, 119435 Moscow,Russian Federation.

V.N. Orekhovich Institute of Biomedical Chemistry, 10, Pogodinskaya street, 119435 Moscow,Russian Federation.

出版信息

Curr Med Chem. 2021;28(40):8416-8432. doi: 10.2174/0929867328666210208113919.

DOI:10.2174/0929867328666210208113919
PMID:33557730
Abstract

This mini-review focuses on the investigation of novel nitrogen-containing steroid derivatives that are potentially applicable for prostate cancer treatment. It covers the literature of the last decade, highlighting the structure of new steroid compounds that exhibit significant activity in prostate cancer cells and possess pharmacological potency. New derivatives of known anti-prostate cancer agents: abiraterone and galeterone, new derivatives of androstane and pregnane modified with nitrogen-containing heterocycles, and some related steroid-derived compounds are discussed in the review.

摘要

这篇小型综述专注于研究新型含氮甾体衍生物,这些衍生物可能适用于前列腺癌的治疗。它涵盖了过去十年的文献,重点介绍了在前列腺癌细胞中表现出显著活性并具有药理效力的新型甾体化合物的结构。本综述讨论了已知抗前列腺癌药物阿比特龙和加榴他滨的新型衍生物、用含氮杂环修饰的雄烷和孕烷的新型衍生物,以及一些相关的甾体衍生化合物。

相似文献

1
Novel Nitrogen Containing Steroid Derivatives for Prostate Cancer Treatment.用于前列腺癌治疗的新型含氮甾体衍生物。
Curr Med Chem. 2021;28(40):8416-8432. doi: 10.2174/0929867328666210208113919.
2
Oxazolinyl derivatives of androst-16-ene as inhibitors of CYP17A1 activity and prostate carcinoma cells proliferation: Effects of substituents in oxazolinyl moiety.雄甾-16-烯的恶唑啉衍生物作为 CYP17A1 活性和前列腺癌细胞增殖的抑制剂:恶唑啉部分取代基的影响。
J Steroid Biochem Mol Biol. 2023 Jun;230:106280. doi: 10.1016/j.jsbmb.2023.106280. Epub 2023 Mar 3.
3
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis.抗前列腺癌CYP17A1抑制剂对雄激素生物合成的特异性。
Biochem Biophys Res Commun. 2016 Sep 2;477(4):1005-1010. doi: 10.1016/j.bbrc.2016.07.019. Epub 2016 Jul 6.
4
17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.17(E)-皮可啉基雄烷衍生物作为潜在的前列腺癌细胞生长抑制剂:增殖抑制活性和分子对接研究。
Bioorg Med Chem. 2013 Dec 1;21(23):7257-66. doi: 10.1016/j.bmc.2013.09.063. Epub 2013 Oct 3.
5
Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.[17(20)E]-21-去甲孕烯恶唑啉基和苯并恶唑基衍生物作为CYP17A1活性抑制剂和前列腺癌细胞生长抑制剂的比较。
Steroids. 2018 Jan;129:24-34. doi: 10.1016/j.steroids.2017.11.009. Epub 2017 Nov 26.
6
[Prostate cancer and new hormonal treatments: mechanism of action and main clinical results].[前列腺癌与新的激素治疗:作用机制及主要临床结果]
Prog Urol. 2013 Oct;23 Suppl 1:S34-43. doi: 10.1016/S1166-7087(13)70044-7.
7
[CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].[CYP17A1抑制剂在前列腺癌中的作用:独立于雄激素途径的作用机制]
Prog Urol. 2013 Oct;23 Suppl 1:S9-15. doi: 10.1016/S1166-7087(13)70041-1.
8
Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.新型雄激素合成抑制剂对激素依赖性前列腺癌的抗雄激素作用
Cancer Res. 2000 Dec 1;60(23):6630-40.
9
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.肿瘤内从头合成类固醇激活去势抵抗性前列腺癌中的雄激素受体,并被 CYP17A1 抑制剂治疗上调。
Cancer Res. 2011 Oct 15;71(20):6503-13. doi: 10.1158/0008-5472.CAN-11-0532. Epub 2011 Aug 25.
10
Hedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate Cancer.刺猬蛋白消耗甾体类CYP17A1拮抗剂:对晚期前列腺癌的潜在治疗意义
ChemMedChem. 2016 Sep 20;11(18):1983-6. doi: 10.1002/cmdc.201600238. Epub 2016 Jul 20.

引用本文的文献

1
Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives.甾体酶抑制剂作为抗癌药物的发现与开发:现状与未来展望。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2483818. doi: 10.1080/14756366.2025.2483818. Epub 2025 Apr 2.
2
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review.人类细胞色素P450与癌症相关的代谢活性及基因多态性:综述
Cells. 2024 Nov 26;13(23):1958. doi: 10.3390/cells13231958.
3
Exploring the Chemical Space of CYP17A1 Inhibitors Using Cheminformatics and Machine Learning.
运用 cheminformatics 和机器学习探索 CYP17A1 抑制剂的化学空间。
Molecules. 2023 Feb 9;28(4):1679. doi: 10.3390/molecules28041679.